LONDON — The European Medicines Agency says people who have received a first dose of AstraZeneca’s COVID-19 vaccine should get the second one, too.
In guidance issued on Friday, the EU drug regulator says people should continue to get a second AstraZeneca dose four to 12 weeks after their first shot despite the rare risk of blood clots linked to the shot.
The Amsterdam-based drug regulator for the 27-nation European Union said earlier this month there was a “possible link” between the AstraZeneca vaccine and rare blood clotting disorders. But it said the benefits of getting the shots outweighed the risks.
The EMA previously described the clots as “very rare” side effects and said the vaccine labels should be modified so doctors and patients are aware. According to data from Britain, which has administered more AstraZeneca vaccines than any other country, there were 30 such cases among 18 million inoculations by late March.